팝업레이어 알림

AI-Driven Target Discovery

Gradiant Bioconvergence

Patient-Derived Organoid

Gradiant Bioconvergence

iPSC-Derived Organoid

Gradiant Bioconvergence

Business

Gradiant Bioconvergence challenges new methods of
drug development based on patient information
by securing proprietary organoid culture technology,
continuous expansion of patient-derived organoid banking,
systematic banking management system, development of various
drug evaluation platforms, and innovative AI analysis algorithms.

PDO Banking

The Largest PDO Bank in Asia

View More

PDO Banking

Target Discovery

AI-Driven Target Discovery using PDOs

View More

Target Discovery

iPSC-Derived Organoid

Customized Collaboration

View More

iPSC-Derived Organoid

Biomaterials

Optimized for Organoid Culture

View More

Biomaterials

Press Release

View More

Notice